Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Urothelial Bladder Cancer 1Recurrence 1Disease Progression 1

Interventions

Nivolumab 3tivozanib 1regorafenib 1niraparib 1neratinib 1lutetium Lu 177 dotatate 1encorafenib 1durvalumab 1copanlisib 1capivasertib 1Valproic Acid 1Thioctic Acid 1Oxaliplatin 1Multiparametric Magnetic Resonance Imaging 1Leucovorin 1Lenalidomide 1Gemcitabine 1Fulvestrant 1Folfox protocol 1Fluorouracil 1Cisplatin 1Cetuximab 1Bortezomib 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Multiparametric Magnetic Resonance Imaging × 90 days × Clear all
NCT04692675 2026-05-06

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase NA Recruiting
508 enrolled
Genitourinary

Prostatic Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡